These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 25542094)

  • 21. Ets1 suppresses atopic dermatitis by suppressing pathogenic T cell responses.
    Lee CG; Kwon HK; Kang H; Kim Y; Nam JH; Won YH; Park S; Kim T; Kang K; Rudra D; Jun CD; Park ZY; Im SH
    JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30843878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current and emerging biologic and small molecule therapies for atopic dermatitis.
    Li R; Hadi S; Guttman-Yassky E
    Expert Opin Biol Ther; 2019 Apr; 19(4):367-380. PubMed ID: 30672355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets.
    Fujita H; Shemer A; Suárez-Fariñas M; Johnson-Huang LM; Tintle S; Cardinale I; Fuentes-Duculan J; Novitskaya I; Carucci JA; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2011 Sep; 128(3):574-82.e1-12. PubMed ID: 21704361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oleanolic acid acetate inhibits atopic dermatitis and allergic contact dermatitis in a murine model.
    Choi JK; Oh HM; Lee S; Park JW; Khang D; Lee SW; Lee WS; Rho MC; Kim SH
    Toxicol Appl Pharmacol; 2013 May; 269(1):72-80. PubMed ID: 23499868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases.
    Malik K; Guttman-Yassky E
    J Investig Dermatol Symp Proc; 2018 Jan; 19(1):S62-S64. PubMed ID: 29273110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic pipeline for atopic dermatitis: End of the drought?
    Paller AS; Kabashima K; Bieber T
    J Allergy Clin Immunol; 2017 Sep; 140(3):633-643. PubMed ID: 28887947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy.
    Ariëns LFM; Bakker DS; van der Schaft J; Garritsen FM; Thijs JL; de Bruin-Weller MS
    Ther Adv Chronic Dis; 2018 Sep; 9(9):159-170. PubMed ID: 30181845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibodies for the treatment of atopic dermatitis.
    Renert-Yuval Y; Guttman-Yassky E
    Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):356-364. PubMed ID: 29870461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New era of biologic therapeutics in atopic dermatitis.
    Guttman-Yassky E; Dhingra N; Leung DY
    Expert Opin Biol Ther; 2013 Apr; 13(4):549-61. PubMed ID: 23323893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New insights into atopic dermatitis.
    Leung DY; Boguniewicz M; Howell MD; Nomura I; Hamid QA
    J Clin Invest; 2004 Mar; 113(5):651-7. PubMed ID: 14991059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Atopic dermatitis of the adult].
    Hello M; Aubert H; Bernier C; Néel A; Barbarot S
    Rev Med Interne; 2016 Feb; 37(2):91-9. PubMed ID: 26617291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of biologics in atopic dermatitis.
    Wu J; Guttman-Yassky E
    Expert Opin Biol Ther; 2020 May; 20(5):525-538. PubMed ID: 32003247
    [No Abstract]   [Full Text] [Related]  

  • 33. Lesional skin in atopic dogs shows a mixed Type-1 and Type-2 immune responsiveness.
    Schlotter YM; Rutten VP; Riemers FM; Knol EF; Willemse T
    Vet Immunol Immunopathol; 2011 Sep; 143(1-2):20-6. PubMed ID: 21684616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in the pathophysiology of atopic dermatitis revealed by novel therapeutics and clinical trials.
    Yang X; Kambe N; Takimoto-Ito R; Kabashima K
    Pharmacol Ther; 2021 Aug; 224():107830. PubMed ID: 33662453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting cytokines and signaling molecules related to immune pathways in atopic dermatitis: therapeutic implications and challenges.
    Kim HO
    Arch Pharm Res; 2022 Dec; 45(12):894-908. PubMed ID: 36462097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The evolving landscape of biologic therapies for atopic dermatitis: Present and future perspective.
    David E; Ungar B; Renert-Yuval Y; Facheris P; Del Duca E; Guttman-Yassky E
    Clin Exp Allergy; 2023 Feb; 53(2):156-172. PubMed ID: 36653940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dupilumab, A Monoclonal Antibody for Atopic Dermatitis: A Review of Current Literature.
    Blakely K; Gooderham M; Papp K
    Skin Therapy Lett; 2016 Mar; 21(2):1-5. PubMed ID: 27223113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis.
    Mashiko S; Bouguermouh S; Rubio M; Baba N; Bissonnette R; Sarfati M
    J Allergy Clin Immunol; 2015 Aug; 136(2):351-9.e1. PubMed ID: 25792465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atopic dermatitis epidemiology and unmet need in the United Kingdom.
    Cork MJ; Danby SG; Ogg GS
    J Dermatolog Treat; 2020 Dec; 31(8):801-809. PubMed ID: 31631717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of T cell receptor (TCR) BV-gene clonotypes in NC/Nga mice developing dermatitis resembling human atopic dermatitis.
    Matsuoka A; Kato T; Soma Y; Takahama H; Nakamura M; Matsuoka H; Mizoguchi M
    J Dermatol Sci; 2005 Apr; 38(1):17-24. PubMed ID: 15795120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.